Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988:181-7.

Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system

Affiliations

Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system

R Shapiro et al. Clin Transpl. 1988.

Abstract

From January 1, 1986 to July 30, 1988, 530 consecutive cadaver kidney transplantations were performed with patient selection by a point system that took into account time awaiting an organ, donor-recipient matching, degree of presensitization, and some less important factors. The effect of the system was to diminish judgmental factors in case selection which in the past, had probably operated to the disadvantage of "undesirable" potential recipients, including older ones. Primary 1-year graft survival (74%) and graft survival after retransplantation (71%) were lower than in the earlier time. However, the results with triple-drug therapy using CsA, AZA and P demonstrated 88% 1-year graft survival for primary graft recipients and 74% in highly sensitized patients, with comparable patient mortality. These latter observations provide some assurance that the concepts of equitable access and efficient utilization of a scarce resource are not mutually exclusive.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient and graft survival for 1986–1987.
Figure 2
Figure 2
Pediatric and adult graft survival for 1986–1987.
Figure 3
Figure 3
Primary and retransplant graft survival for 1986–1987.
Figure 4
Figure 4
Graft survival for PRA less than and greater than 40%.
Figure 5
Figure 5
Graft survival for two- and three-drug immunosuppression.
Figure 6
Figure 6
Pediatric and adult graft survival with two- and three-drug immunosuppression.
Figure 7
Figure 7
Primary and retransplant graft survival with two- and three-drug immunosuppression.
Figure 8
Figure 8
Graft survival for PRA less than and greater than 40% with two- and three-drug immunosuppression.

References

    1. Starzl TE, Hakala T, Tzakis A, Gordon R, Stieber A, Makowka L, Klimoski J, Bahnson H. A multifactorial system for equitable selection of cadaveric kidney recipients. JAMA. 1987;257:3073–3075. - PMC - PubMed
    1. Shapiro R, Tzakis AG, Hakala TR, Lopatin W, Mitchell S, Koneru B, Stieber A, Gordon RD, Starzl TE. Cadaveric renal transplantation under the American organ allocation system. Contr Nephrol. (In Press). - PMC - PubMed
    1. Starzl TE. Experience in Renal Transplantation. Philadelphia: WB Saunders Company; 1964.
    1. Lich R, Jr, Howerton, Connie W, Davis O, Lawrence A. Recurrent urosepsis in children. J Urol. 1961;86:554–558.
    1. Woofruff MFA, Nolan B, Robson JS, MacDonald MK. Renal transplantation in man: Experience in 35 cases. Lancet. 1969;1:6–12. - PubMed